Nazione: Sudafrica
Lingua: inglese
Fonte: South African Health Products Regulatory Authority (SAHPRA)
Lennon
ERYTHROMYCIN ETHYLSUCCINATE 125 mg - LENNON Granules for Suspension ERYTHROMYCIN ETHYLSUCCINATE 250 mg - LENNON Granules for Suspension SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): ERYTHROMYCIN ETHYLSUCCINATE 125 mg - LENNON Granules for Suspension ERYTHROMYCIN ETHYLSUCCINATE 250 mg - LENNON Granules for Suspension COMPOSITION: Each 5 mL of the reconstituted suspension contains: (1) Erythromycin ethylsuccinate equivalent to 125 mg erythromycin base (2) Erythromycin ethylsuccinate equivalent to 250 mg erythromycin base Preserved with: 0,03% m/v propylhydroxybenzoate sodium 0,06% m/v methyl hydroxybenzoate sodium PHARMACOLOGICAL CLASSIFICATION: A 20.1.1 Broad and medium spectrum antibiotics. PHARMACOLOGICAL ACTION: Erythromycin has bacteriostatic activities with a range of antimicrobial action which is similar to that of penicillin G. It is active against some Gram-positive bacteria, some Gram-negative bacteria (Neisseria and Haemophilus), spirochaetes, some rickettsias, Streptococcus pneumoniae, haemolytic streptococci, and corynebacteria. Staphylococci (including those resistant to penicillin) are rather less sensitive. During prolonged treatment of infections, the development of resistant strains is common. INDICATIONS: Erythromycin is an agent for use in individuals unable to take penicillin because of previous reactions. Pharyngitis, Scarlet Fever anderysipelas produced by group-A Streptococcus pyogenes respond to erythromycin. Erythromycin is useful in cases in which the presence of penicillinase-producing staphylococci may be responsible for relapse of streptococcal pharyngitis after adequate treatment with penicillin G, and other infections due to enterococci may also respond well to the drug. Erythromycin is effective in eradicating the acute or chronic diphtheria bacillus carrier Leggi il documento completo